Skip to main content
Figure 6 | Breast Cancer Research

Figure 6

From: Dose-dense adjuvant chemotherapy for primary breast cancer

Figure 6

Phase III adjuvant trial comparing standard versus accelerated 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) regimen in early breast cancer patients. Results from the Gruppo Oncologico del Nord-Ovest group MIG1 study. G-CSF, granulocyte colony-stimulating factor. Adapted from Venturini and coworkers [22].

Back to article page
\